Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

Das, S., Vital, E.M., Horton, S., Bryer, D., El-Sherbiny, Y. ORCID: 0000-0003-4791-3475, Rawstron, A.C., Ponchel, F., Emery, P. and Buch, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967

Full text not available from this repository.
Item Type: Journal article
Publication Title: Annals of the Rheumatic Diseases
Creators: Das, S., Vital, E.M., Horton, S., Bryer, D., El-Sherbiny, Y., Rawstron, A.C., Ponchel, F., Emery, P. and Buch, M.H.
Publisher: BMJ
Date: 2014
Volume: 73
Number: 5
ISSN: 0003-4967
Identifiers:
NumberType
10.1136/annrheumdis-2013-204417DOI
1199943Other
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 14 Oct 2019 14:51
Last Modified: 14 Oct 2019 14:51
URI: http://irep.ntu.ac.uk/id/eprint/37954

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year